Breast cancer is the second leading cause of cancer death in women...
Category:
Health
Latest
Free services at government hospitals in Maharashtra from Tuesday
Among other things, common tests and screenings such as X-ray, ECG,...
NHA and IRDAI hold workshop to help insurers integrating with ABDM and NHCX
Speaking about the outcomes from this workshop, CEO, NHA said –...
UN World Happiness Report 2021: India ranks 139 out of 149 nations, Pakistan happier at 105
The World Happiness Report 2021, issued by the UN Sustainable Development Solutions Network, focuses on the effects of Covid-19 and how people all over the world have fared.Finland has been ranked as the happiest country in the world. The Nordic nation is followed by Iceland, Denmark, Switzerland, The Netherlands, Sweden, Germany and Norway.
Pakistan is on 105th, Bangladesh on 101st and China on 84th, according to the report.
People in war-torn Afghanistan are the most unhappy with their lives, followed by Zimbabwe (148), Rwanda (147), Botswana (146) and Lesotho (145).
Global Covid-19 caseload tops 122.2 million: Johns Hopkins University
Nations with a death toll of over 50,000 are India (159,370), the UK (126,263), Italy (104,241), Russia (92,704), France (91,833), Germany (74,466), Spain (72,910), Colombia (61,771), Iran (61,649), Argentina (54,476) and South Africa (52,035).
Govt has taken number of steps to bring down pollution in Delhi: Javadekar
Responding to a question on pollution in the national capital during the Question Hour in Lok Sabha, Javadekar said air pollution in Delhi is the ”most serious problem”, and noted that the air quality along the Indo-Gangetic belt is poor.
To address the issue of pollution in 100 cities, a National Clean Air Programme (NCAP) was also launched and a plan has been made for every city, Javadekar said.
Covid vaccine should be able to give protection for 8-10 months: AIIMS director
“The Covid-19 vaccine should be able to give good protection from the infection for eight to ten months and maybe, even more,” Guleria said at an event organised by the IPS (Central) Association.
AstraZeneca counters Indonesian Muslim concerns over COVID-19 vaccine
AstraZeneca Indonesia spokesman Rizman Abudaeri said in a statement: “At all stages of the production process, this virus vector vaccine does not use nor come in contact with pork-derived products or other animal products.”
Over 40,000 coronavirus cases recorded in India, highest in 111 days
Registering an increase for the tenth day in a row, the total active caseload has reached 2,88,394, which now comprises 2.49 per cent of the total infections, while the recovery rate has further dropped to 96.12 per cent, the data stated.
Cancer survivors face elevated heart disease risk: Study
“We know that obesity, cancer and cardiovascular disease share some common risk factors, and in addition to those shared risk factors, cancer patients also receive treatments including radiation and chemotherapy that can affect their cardiovascular health — we call that cardiotoxicity,” said lead researcher Xiaochen Zhang from The Ohio State University.
Irdai lowers min cover, raises max cover under Arogya Sanjeevani policy
“In order to enhance the coverage available under Arogya Sanjeevani Policy, in partial modification of the extant guidelines, insurers shall mandatorily offer the sum insured between Rs 50,000 to Rs 10,00,000 under the standard product Arogya Sanjeevani w.e.f 1st May, 2021 or earlier,” Irdai said in a circular addressed to the general and standalone health insurers.
EU countries to resume AstraZeneca vaccinations after ‘Safe, Effective’ verdict from WHO
The closely-watched announcement from the European Medicines Agency (EMA) came after the WHO and Britain’s health watchdog both said the vaccine was safe, adding that it was far riskier to not get the shot as several countries face a worrying rise in coronavirus cases.
However, Norway and Sweden said they were not ready to resume using the vaccine.
COVID-19 patients above 65 years of age more prone to reinfection, says study
“Our study confirms what a number of others appeared to suggest — reinfection with COVID-19 is rare in younger, healthy people, but the elderly are at greater risk of catching it again,” said study co-author Steen Ethelberg, from the Statens Serum Institut.
“Since older people are also more likely to experience severe disease symptoms, and sadly die, our findings make clear how important it is to implement policies to protect the elderly during the pandemic,” Ethelberg said.